Testicular teratocarcinogenesis in mice - A review

APMIS

Volumn 106, Issue 1, 1998, Pages 174-182

  Matin, Angabin ^a   Collin, Gayle B ^b   Varnum, Don S ^b   Nadeau, Joseph H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Germ cell tumours; Mice; Ter; Teratocarcinoma; Teratoma

Indexed keywords

CANCER INCIDENCE; CARCINOGENESIS; CONFERENCE PAPER; CYTOGENETICS; GENE MAPPING; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM CELL TUMOR; MOUSE; NONHUMAN; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; TERATOCARCINOMA; TESTIS TERATOMA;

EID: 0031914245     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb01333.x     Document Type: Conference Paper

References (57)

1. Ahlberg, N. A., Bartley, O., Chidekd, N. & Fritjofsson, A.: Phlebography in varicocele scroti. Acta Radiol: Diagnosis 4: 517-528, 1966.
2. Andervont, H. B., Shimkin, M. B. & Canter, H. Y.: Susceptibility of seven inbred strains and the F1 hybrids to estrogen-induced testicular tumors and occurrence of spontaneous testicular tumors in strain BALB/c mice. J. Natl. Cancer Inst. 25: 1069-1081, 1960.
3. Asada, Y., Varnum, D. S., Frankel, W. N. & Nadeau, J. H.: A mutation in the Ter gene causing increased susceptibility to testicular teratomas maps to mouse chromosome 18. Nature Genetics 6: 363-368, 1994.
4. Bedell, M. A., Cleveland, L. S., O'Sullivan, T. N., Copeland, N. G. & Jenkins, N. A.: Deletion and interallelic complementation analysis of Steel mutant mice. Genetics 142: 935-944, 1996.
5. Bosland, M. C.: Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Prog. Clin. Biol. Res. 394: 309-352, 1996.
6. Coolsaet, B. L.: The varicocele syndrome: venography determining the optimal level for surgical management. J. Urology 124: 833-839, 1980.
7. Chaganti, R. S. K., Rodriguez, E. & Bosl, G. J.: Cytogenetics of male germ-cell tumors. Urologie Clinics of N. America 20: 55-66, 1993.
8. Chilvers, C.: Epidemiology of undescended testis. In: Oliver, R. T. D. (Ed.), Urological and Genital Cancer, pp 250-261. Blackwell, Oxford. 1989.
9. Collin, G. B., Asada, Y., Varnum, D. S. & Nadeau, J. H.: DNA pooling as a quick method for finding candidate linkages in multigenic trait analysis: an example involving susceptibility to germ cell tumors. Mamm. Genome 7: 68-70, 1996.
10. Dewey, M. J., Gearhart, J. D. & Mintz, B.: Cell surface antigens of totipotent mouse teratocarcinoma cells grown in vivo: Their relation to embryo, adult, and tumor antigens. Dev Biol. 55: 359-374, 1977.
11. Dewey, M. J., Filler, R. & Mintz, B.: Protein patterns of developmentally totipotent mouse teratocarcinoma cells and normal early embryo cells. Dev. Biol. 65: 171-182, 1978.
12. Dolci, S., Williams, D. E., Ernst, M. K., Resnick, J. L., Brannan, C. I., Lock, L. F., Lyman, S. D., Boswell, H. S. & Donovan, P. J.: Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature 352: 809-811, 1991.
13. Doetschman, T., Gregg, R. G., Maeda, N., Hooper, M. L., Melton, D. W., Thompson, S. & Smithies, O.: Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330: 576-578, 1987.
14. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery Jr., C. A., Butel, J. S. & Bradley, A.: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221, 1992.
15. Duhl, D. M., Stevens, M. E., Vrieling, H., Saxon, P. J., Miller, M. W., Epstein, C. J. & Barsh, G. S.: Pleiotropic effects of the mouse lethal yellow (Ay) mutation explained by deletion of a maternally expressed gene and the simultaneous production of agouti fusion RNAs. Development 120: 1695-1708, 1994.
16. Giwercman, A., Bruun, E., Frimodt-Moller, C. & Skakkebæk, N. E.: Prevalence of carcinoma-in-situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J. Urology 142: 998-1002, 1989.
17. Harvey, M., McArthur, M. J., Montgomery Jr, C. A., Bradley, A. & Donehower, L. A.: Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7: 938-943, 1993.
18. Hummel, K. P. & Chapman, D. B.: Visceral inversion and associated anomalies in the mouse. J. Hered. 50 : 9-13, 1959.
19. Jacob, F.: Mouse teratocarcinoma and embryonic antigens. Immunol. Rev. 33 : 3-32, 1977.
20. Klebig, M. L., Wilkinson, J. E., Geisler, J. G. & Woychik, R. P.: Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc. Natl. Acad. Sci. USA 92: 4728-4732, 1995.
21. Kleinsmith, L. J. & Pierce, G. B.: Multipotentiality of single embryonal carcinoma cells. Cancer 24: 1544-1552, 1964.
22. Kondoh, G., Nishimune, Y., Nishizawa, Y., Hayasaka, N., Matsumoto, K. & Hakura, A.: Establishment and further characterization of a line of transgenic mice showing testicular tumorigenesis at 100% incidence. J. Urol. 152: 2151-2154, 1994.
23. Lu, D., Willard, D., Patel, I. R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Woychik, R.P., Wilkison, W.O. & Cone, R.: Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature 371: 799-802, 1994.
24. Martin, G. R.: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA. 78: 7634-7638, 1981.
25. Martin, G. R., Smith, S. & Epstein, C. J.: Protein synthetic patterns in teratocarcinoma stem cells and mouse embryos at early stages of development. Dev. Biol. 66 : 8-16, 1978.
26. Michaud, E. J., Bultman, S. J., Klebig, M. L., Vugt, M. J. V., Stubbs, L. J., Russel, L. B. & Woychik, R. P.: A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. Proc. Natl. Acad. Sci. USA. 91: 2562-2566, 1994.
27. Miwa, M., Kojima, M., Ohtani, T. & Tsuji, K.: A recessive mutant causing testicular/ovarian teratoma in rats (tera strain). Exp. Anim. 36: 205-208, 1987.
28. Motro, B., D. V. K., Rossant, J., Reith, A. & Bernstein, A.: Contiguous pattern of c-kit and Steel expression: analysis of mutations at the W and Sl loci. Development 113: 1207-1221, 1991.
29. Nicholson, P. W. & Harland, S. J.: Inheritance and testicular cancer. Br. J. Cancer. 71: 421-426, 1995.
30. Noguchi, T. & Stevens, L. C.: Primordial germ cell proliferation in fetal testes in mouse strains with high and low incidences of congenital testicular teratomas. J.N.C.I. 69: 907-913, 1982.
31. Noguchi, T. & Noguchi, M.: A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice. J.N.C.I. 75: 385-391, 1985.
32. Paquis-Flucklinger, V., Rassoulzadegan, M. & Michiels, J. F.: Experimental Sertoli cell tumors in the mouse and their progression into a mixed germ cell-sex cord proliferation. Am. J. Pathol. 144: 454-459, 1994.
33. Pierce, J., G. B., Dixon, J., F. J. & Verney, E. L.: Teratocarcinogenic and tissue-forming potentials of the cell types comprising neoplastic embryoid bodies. Lab. Investigation 9: 583-602, 1960.
34. Pierce, G. B., Stevens, L. C. & Nakane, P. K.: Ultrastructural analysis of the early development of teratocarcinoma. J. Natl. Cancer Inst. 39: 755-773, 1967.
35. Rossant, J. & Papaioannou, V. E.: The relationship between embryonic, embryonal carcinoma and embryo-derived stem cells. Cell Differ. 15: 155-161, 1984.
36. Sakurai, T., Katoh, H., Moriwaki, K., Noguchi, T. & Noguchi, M.: The ter primordial germ cell deficiency mutation maps near Grl-1 on mouse chromosome 18. Mamm. Genome 5: 333-336, 1994.
37. Sato, B., Spomer, W., Huseby, R. A. & Samuels, L. T.: The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors. Endocrinol. 104: 822-831, 1979.
38. Shikone, T., Matzuk, M. M., Perlas, E., Finegold, M. J., Lewis, K. A., Vale, W., Bradley, A. & Hsueh, A. J.: Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor. Mol. Endocrinol. 8: 983-995, 1994.
39. Silver, L. M., Martin, G. R. & Strickland, S. (Eds.): Teratocarcinoma stem cells. Cold Spring Harbor Conferences on Cell Proliferation 10, 1983.
40. Soriano P.: Gene targeting in ES cells. Annual Review of Neuroscience 18:1-18, 1995.
41. Stevens, L. C. & Hummel, K. P.: A description of spontaneous congenital testicular teratomas in strain 129 mice. J.N.C.I. 18: 719-747, 1957.
42. Stevens, L. C.: Studies on transplantable testicular teratomas of strain 129 mice. J.N.C.I. 20: 1257-1275, 1958.
43. Stevens, L. C. & Mackensen, J. A.: Genetic and environmental influences on testicular teratocarcinogenesis in mice. J.N.C.I. 27: 443-453, 1961.
44. Stevens, L. C.: Testicular teratomas in fetal mice. J. Natl. Cancer Inst. 28: 247-267, 1962.
45. Stevens, L. C. & Bunker, M. C.: Karyotype and sex of primary testicular teratomas in mice. J.N.C.I. 33: 65-78, 1964.
46. Stevens, L. C.: Experimental production of testicular teratomas in mice. Proc. Natl. Acad. Sci. USA. 52: 654-661, 1964.
47. Stevens, L. C.: Development of resistance to teratocarcinogeneis by primordial germ cells in mice. J.N.C.I. 37: 859-867, 1966.
48. Stevens, L. C.: Origin of testicular teratomas from primordial germ cells in mice. J. Natn. Cancer Inst. 38: 549-552, 1967a.
49. Stevens, L. C.: The biology of teratomas. In: Abercrombie, M. & Brachet, J. (Eds): Adv. in Morphogenesis. New York: Academic Press. 8: 1-31, 1967b.
50. Stevens, L. C.: Experimental production of testicular teratomas in mice of strain 129, A/He and their F1 hybrids. J.N.C.I. 44: 923-929, 1970a.
51. Stevens, L. C.: Environmental influence on experimental teratocarcinogenesis in testes of mice. J. Exp. Zoology 174: 407-414, 1970b.
52. Stevens, L. C.: A new inbred subline of mice (129/terSv) with a high incidence of spontaneous congenital testicular teratomas. Natl. Cancer Inst. 50: 235-242, 1973a.
53. Stevens, L. C.: A developmental genetic approach to the study of teratocarcinogenesis. BioScience 23: 169-172, 1973b.
54. Stevens, L. C.: Genetic influences on teratocarcinogenesis and parthenogenesis. Mammalian genetics and cancer: The Jackson laboratory fiftieth anniversary symposium. Alan, R. Liss, Inc., New York, NY: 93-104, 1981.
55. Stevens, L. C.: The origin and development of testicular, ovarian and embryo-derived teratomas. Cold Spring Harbor Conferences on cell proliferation: teratocarcinoma stem cells. Silver, L. M., Martin, G. R. & Strickland, S. (Eds.) 10: 23-36, 1983.
56. Thomas, K. R. & Capecchi, M. R.: Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51: 503-512, 1987.
57. Walker, A. H., Bernstein, L., Warren, D. W., Warner, N. E., Zheng, X. & Henderson, B. E.: The effect of in utero ethinyl oestradiol exposure on the risk of cryptorchid testis and testicular teratoma in mice. Br. J. Cancer 62: 599-602, 1990.